AB71 - Degenerative or Vascular Disorders of the Ear: Complete Coding Guide

1. Introduction

Degenerative or vascular disorders of the ear represent a set of conditions that affect the structure and function of the auditory system due to processes of progressive deterioration or alterations in local blood circulation. These pathologies can significantly compromise patients' quality of life, affecting not only hearing, but also balance and the capacity for social communication.

The clinical importance of these disorders lies in their progressive nature and the impact they exert on auditory functionality. Unlike acute or traumatic conditions, degenerative and vascular processes tend to evolve gradually, requiring continuous monitoring and specific therapeutic interventions. Early identification of these conditions is fundamental for implementing strategies that can delay progression and preserve residual auditory function.

From an epidemiological perspective, these disorders represent a growing concern in public health, especially considering global population aging. Vascular and degenerative alterations of the ear can occur in various age groups, although they are more frequent in adult and elderly populations. The economic impact includes direct costs with specialized treatments, hearing devices and rehabilitation, in addition to indirect costs related to reduced productivity and social isolation.

Correct coding using code AB71 is critical for multiple purposes: it allows appropriate epidemiological tracking, facilitates clinical research on these conditions, aids in resource planning in health services and ensures appropriate reimbursement of procedures performed. Furthermore, precise documentation contributes to continuity of care when the patient transitions between different levels of health care.

2. Correct ICD-11 Code

Code: AB71

Description: Degenerative or vascular disorders of the ear

Parent category: null - Disorders of the ear, not classified elsewhere

This specific ICD-11 code was designated to classify conditions involving progressive deterioration of auricular structures or alterations related to vascularization of the inner, middle, or external ear. Code AB71 encompasses pathological processes that result in functional impairment due to degenerative mechanisms or vascular insufficiency.

The classification within the category of disorders of the ear not classified elsewhere reflects the specific nature of these conditions, which do not fit into the more common categories of auricular pathologies such as infections, trauma, or congenital malformations. This position in the ICD-11 hierarchy allows for clear identification of processes involving progressive structural alterations or circulatory compromise.

Code AB71 is used when the primary etiology of the hearing disorder is related to degenerative processes of auricular tissues or alterations in blood perfusion of ear structures. It is important to emphasize that this code should be applied when these characteristics are the dominant aspect of the clinical presentation, and not when they represent only secondary complications of other systemic conditions.

3. When to Use This Code

The code AB71 should be applied in specific clinical scenarios where there is clear evidence of degenerative or vascular processes affecting the auricular structures. Below, we present detailed practical situations:

Scenario 1: Progressive Cochlear Degeneration Patient presents with progressive bilateral sensorineural hearing loss with audiometric findings demonstrating deterioration across multiple evaluations. Investigation excludes typical presbycusis, occupational noise exposure, and other identifiable causes. Imaging studies reveal degenerative changes in the cochlea without evidence of inflammatory or neoplastic process. This presentation characterizes a primary degenerative process of the inner ear, justifying the use of code AB71.

Scenario 2: Vascular Insufficiency of the Inner Ear Patient with recurrent episodes of sudden hearing loss, vertigo, and tinnitus, associated with evidence of vascular compromise. Studies demonstrate reduced blood flow in the internal auditory artery or its branches. Clinical history may include vascular risk factors, but the primary focus is the auditory manifestation of circulatory insufficiency. Code AB71 is appropriate when the vascular disorder predominantly affects the auricular structures.

Scenario 3: Progressive Atrophy of Middle Ear Structures Identification of degenerative process affecting the ossicular chain or middle ear membranes, without history of chronic infection, trauma, or prior surgery. The patient presents with progressive conductive hearing loss with otoscopic and radiological evidence of degenerative changes. Tympanometry may demonstrate alterations in the compliance of the tympano-ossicular system. This specific scenario of structural degeneration justifies coding with AB71.

Scenario 4: Vascular Changes of the Auricle Degenerative or vascular processes affecting the cartilage and tissues of the auricle, including conditions such as relapsing polychondritis in degenerative phase or chronic ischemic changes. There should be documentation of vascular compromise or progressive tissue degeneration, differentiating from acute inflammatory or traumatic processes.

Scenario 5: Degeneration of the Membranous Labyrinth Patients with evidence of progressive deterioration of labyrinthine structures, manifesting as progressive vestibular dysfunction associated with hearing loss. Vestibular examinations demonstrate progressive hypofunction, and imaging studies may reveal degenerative changes of the membranous labyrinth. This presentation, when not attributable to other specific causes, is appropriately coded as AB71.

Scenario 6: Chronic Vascular Disorders with Auditory Manifestation Situations where there is chronic compromise of auricular microcirculation resulting in persistent or progressive symptoms. May include cases of vasculopathy specifically affecting the inner ear, with documentation of alterations in perfusion through functional or imaging studies. The presence of symptoms such as pulsatile tinnitus, hearing fluctuation, and intermittent vestibular symptoms may support this diagnosis.

4. When NOT to Use This Code

It is fundamental to recognize situations where code AB71 should not be applied, avoiding coding errors that may compromise the accuracy of medical records:

Presbycusis: When hearing loss is clearly attributable to normal physiological aging of the auditory system, the specific code 1569854675 for presbycusis should be used. Differentiation is based on patient age, characteristic audiometric pattern (predominant loss at high frequencies), and absence of other identifiable pathological processes. Presbycusis represents normal aging, not a pathological degenerative process.

Chronic Infections: Chronic infectious processes of the ear, such as chronic otitis media or malignant otitis externa, should be coded in the specific codes for auricular infections. Even if they result in secondary degenerative changes, the primary process is infectious, not degenerative or primary vascular.

Acoustic Trauma: Hearing loss induced by noise or acute acoustic trauma has specific codes and should not be classified as a degenerative disorder, even if it results in permanent structural changes. The traumatic etiology is the determining factor for coding.

Congenital Malformations: Structural alterations present since birth, even if progressive, should be coded as congenital malformations. Code AB71 is reserved for acquired processes that develop after the neonatal period.

Neoplasms: Benign or malignant tumors of the ear, even if they cause secondary degeneration of adjacent structures, should be coded primarily as neoplasms. The neoplastic process takes precedence over secondary degenerative changes.

Systemic Disorders with Auricular Manifestation: When auricular pathology is clearly secondary to a systemic disease (diabetes, autoimmune diseases, metabolic disorders), the primary code should reflect the systemic condition, using AB71 only as an additional code if appropriate.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of the diagnosis of degenerative or vascular disorder of the ear requires systematic and comprehensive evaluation. Begin with a detailed clinical history, focusing on the chronology of symptoms, temporal progression, triggering factors, and history of relevant exposures.

Pure tone and speech audiometry is fundamental to characterize the type and degree of hearing loss. Serial assessments are particularly valuable for documenting the characteristic progression of degenerative processes. Tympanometry complements the evaluation by providing information about middle ear function.

Otoscopic examinations and, when available, videotoscopy allow direct visualization of external and middle ear structures. Degenerative changes can be identified through these assessments. Imaging studies, including computed tomography or magnetic resonance imaging, are frequently necessary to evaluate deep structures and identify degenerative or vascular changes.

Vestibular tests may be indicated when there are symptoms of imbalance or vertigo, helping to characterize labyrinthine involvement. Auditory evoked potential studies can provide information about the integrity of central auditory pathways.

Step 2: Verify Specifiers

After confirming the diagnosis, it is important to document specific characteristics that may influence management and prognosis. The severity of hearing impairment should be classified according to audiometric thresholds: mild, moderate, severe, or profound.

Laterality is an important specifier: right unilateral, left unilateral, or bilateral. Temporal progression should be characterized: acute, subacute, or chronic. Degenerative processes typically present with chronic and progressive evolution, whereas vascular events may have a more sudden onset.

Document the presence of associated symptoms such as tinnitus, vertigo, aural fullness, or otalgia. These symptoms may indicate involvement of specific structures and help with diagnostic differentiation. Response to previous treatments should also be recorded, as it may provide important prognostic information.

Step 3: Differentiate from Other Codes

AB70: Otalgia or otitis media with effusion The fundamental difference is that AB70 focuses on specific symptoms (pain) or presence of fluid in the middle ear, generally related to acute or subacute processes. AB71 refers to chronic degenerative or vascular processes. If the patient presents primarily with ear pain or effusion without evidence of underlying degenerative or vascular process, AB70 is more appropriate.

AB72: Disorders of the acoustic nerve This code is specific for pathologies that primarily affect the auditory nerve (cranial nerve VIII), such as vestibular neuritis or vestibular schwannoma. AB71 is used when the degenerative or vascular process affects the structures of the ear itself (internal, middle, or external), not specifically the nerve. The distinction can be made through evoked potential and imaging studies.

AB73: Atrophy of the ear Although related, AB73 is more specific for pure atrophic processes, where there is reduction in volume or tissue loss. AB71 is more comprehensive, including degenerative processes that may not necessarily result in evident atrophy, and also encompasses vascular disorders. Use AB73 when atrophy is the dominant and documented characteristic.

Step 4: Required Documentation

Adequate documentation is essential to justify coding with AB71. The medical record should include:

Checklist of Mandatory Information:

Detailed description of auditory and vestibular symptoms
Chronology and pattern of symptom progression
Audiometry results with dates and specific values
Findings from otoscopic or videotoscopic examination
Results of imaging studies when performed
Exclusion of other specific causes (infection, trauma, neoplasia)
Evidence of degenerative or vascular process (specific description)
Assessment of relevant comorbidities
Implemented therapeutic plan
Response to previous treatments

The record should be sufficiently detailed to allow another professional to clearly understand why code AB71 was selected. Avoid vague terms; be specific about the findings that characterize the process as degenerative or vascular.

6. Complete Practical Example

Clinical Case

A 58-year-old patient presents to the otolaryngology service with a complaint of progressive bilateral hearing loss, more pronounced on the left, with a course of approximately three years. He also reports intermittent bilateral tinnitus and occasional episodes of postural instability, without frank rotatory vertigo.

In the clinical history, he denies occupational exposure to intense noise, previous head trauma, or use of ototoxic medications. There is no family history of early hearing loss. He reports arterial hypertension controlled with medication and dyslipidemia. He denies smoking or excessive alcohol consumption.

On otoscopic examination, intact tympanic membranes are observed bilaterally, with a slightly opaque appearance and mild retraction on the left, without signs of active infection or effusion. There are no alterations in the external auditory canal or auricle.

Pure tone audiometry revealed bilateral sensorineural hearing loss, moderate on the left (thresholds between 40-60 dB) and mild on the right (thresholds between 25-40 dB), with a descending configuration. Speech discrimination was proportionally reduced. Previous audiometries, performed 18 months ago, demonstrated progression of approximately 10-15 dB at multiple frequencies.

Tympanometry showed type A curves bilaterally, suggesting normal middle ear function, but with reduced compliance on the left. Stapedial reflexes present bilaterally, but with elevated thresholds.

Magnetic resonance imaging of the ears and cerebellopontine angle was performed, demonstrating signs of bilateral cochlear degenerative changes, more pronounced on the left, with reduction of the labyrinthine fluid signal. No expansive lesions, malformations, or signs of active inflammatory processes were identified. There were also signs suggestive of labyrinthine microcirculation compromise.

Vestibular tests (videonystagmography) revealed mild vestibular hypofunction on the left, compatible with peripheral labyrinthine compromise.

Step-by-Step Coding

Criteria Analysis:

Evidence of degenerative process: Magnetic resonance imaging documents progressive cochlear degenerative changes, and serial audiometries confirm progressive deterioration of auditory function.
Vascular component: Signs of labyrinthine microcirculation compromise on magnetic resonance imaging, associated with vascular risk factors (hypertension, dyslipidemia).
Exclusion of other causes: There is no evidence of typical presbycusis (relatively young age, faster progression than expected), acoustic trauma, infection, neoplasia, or congenital malformation.
Documented progression: Comparison with previous examinations demonstrates objective deterioration over time.

Code Chosen: AB71 - Degenerative or vascular disorders of the ear

Complete Justification:

Code AB71 is most appropriate because the clinical presentation is dominated by a documented degenerative process of cochlear structures, with an associated vascular component. The documented progression, characteristic imaging findings, and exclusion of other specific etiologies support this coding.

We did not use the code for presbycusis (1569854675) because the patient is relatively young and the progression is faster than expected for normal physiological aging. We did not use AB72 (acoustic nerve disorders) because the alterations are primarily cochlear, not of the nerve itself. AB73 (ear atrophy) is not appropriate because, although there is degeneration, atrophy is not the dominant characteristic.

Complementary Codes:

Codes may be added to document relevant comorbidities (hypertension, dyslipidemia) and specific symptoms (tinnitus, instability) if the coding system allows multiple diagnoses. This provides a more complete picture of the patient's condition.

7. Related Codes and Differentiation

Within the Same Category

AB70: Ear pain or ear effusion

Use AB70 when the predominant symptom is ear pain or when there is presence of fluid in the middle ear confirmed by otoscopy or tympanometry. This code is more appropriate for acute or subacute conditions such as otitis media with effusion, barotrauma, or non-infectious inflammatory processes.

The main difference in relation to AB71 is that AB70 focuses on specific symptomatic manifestations (pain and effusion) generally of a transient nature, while AB71 refers to chronic and progressive pathological processes that alter the structure and function of auricular structures. A patient may initially present with AB70 and, if they develop chronic degenerative sequelae, subsequently be coded as AB71.

AB72: Acoustic nerve disorders

This code is specific for pathologies affecting the VIII cranial nerve (vestibulocochlear nerve). It includes conditions such as vestibular neuritis, auditory neuropathy, vestibular schwannoma, and other lesions that primarily compromise neural transmission.

The main difference is anatomical and functional: AB72 refers to problems in the auditory nerve after the synapse of hair cells, while AB71 involves structures of the external, middle, or inner ear (including cochlea and labyrinth). Differentiation can be made through brainstem auditory evoked potentials and contrast-enhanced magnetic resonance imaging focused on the internal auditory canal.

AB73: Ear atrophy

AB73 is used when there is clear evidence of tissue atrophy, characterized by reduction in volume or loss of substance of auricular structures. It may affect the auricle, external auditory canal, or internal structures.

The main difference in relation to AB71 is that AB73 is more specific for documented atrophic processes, while AB71 is more comprehensive, including degenerative processes that may not result in evident atrophy, and also specifically includes vascular disorders. Use AB73 when atrophy is the dominant and clearly documented feature; use AB71 when there is degeneration or vascular compromise without significant atrophy or when both processes coexist without clear predominance of atrophy.

Differential Diagnoses

Various conditions may be confused with degenerative or vascular disorders of the ear:

Ménière's disease: Characterized by recurrent episodes of intense rotatory vertigo, fluctuating hearing loss, tinnitus, and aural fullness. Although there may be secondary degenerative component, Ménière's disease has a specific code and distinct pathophysiology (endolymphatic hydrops).

Ototoxicity: Hearing loss related to ototoxic medications has specific etiology and should be coded as such, even if it results in permanent degenerative changes. The history of medication exposure is the key differentiating factor.

Otosclerosis: Specific condition characterized by fixation of the ossicular chain due to abnormal bone remodeling. Although it is a progressive process, it has specific pathophysiology and code, differentiating it from general degenerative processes.

8. Differences with ICD-10

In ICD-10, degenerative and vascular disorders of the ear did not have a unique specific code comparable to AB71. These conditions were often coded under broader categories such as H83 (Other disorders of the inner ear) or H95 (Disorders of the ear and mastoid process following procedures, not classified elsewhere), depending on the specific clinical context.

The main change in ICD-11 is the creation of a specific code (AB71) that explicitly groups degenerative and vascular processes, providing greater specificity and clarity in coding. This reflects recognition of the clinical importance of these conditions and the need for more precise epidemiological tracking.

The practical impact of these changes includes improved ability to identify and study these specific conditions in health databases, facilitating research on prevalence, risk factors, and treatment efficacy. For health professionals, it means greater precision in documentation and communication about these conditions.

The transition from ICD-10 to ICD-11 requires that coders and health professionals become familiar with this new specific category, recognizing that conditions previously coded in a more generic manner now have a dedicated code. This may impact health information systems, which will need to be updated to incorporate the new code and establish appropriate mappings with previous codes for historical analyses.

9. Frequently Asked Questions

How is the diagnosis of degenerative or vascular disorders of the ear made?

The diagnosis is established through a combination of clinical evaluation, audiological examinations, and imaging studies. Audiometry is fundamental for characterizing the type and degree of hearing loss, while serial evaluations document the characteristic progression. Imaging examinations, particularly magnetic resonance imaging, can identify degenerative structural changes and signs of vascular compromise. The exclusion of other specific causes through detailed clinical history and appropriate investigation is essential to confirm the diagnosis.

Is treatment available in public health systems?

The availability of treatment varies according to the resources of each health system, but generally includes options available in public services. Management may involve control of vascular risk factors, use of medications to improve labyrinthine circulation, vestibular rehabilitation, and adaptation of hearing aids when indicated. More specialized treatments may have variable availability depending on the level of complexity of the service.

How long does treatment last?

Treatment of degenerative or vascular disorders of the ear is typically long-term, often requiring continuous follow-up. The chronic and progressive nature of these conditions means that management is often lifelong, with therapeutic adjustments as the disease progresses. Periodic evaluations are necessary to monitor progression and adjust interventions, usually performed every six to twelve months, or more frequently if there is significant deterioration.

Can this code be used in medical certificates?

Yes, the code AB71 can and should be used in official medical documentation, including certificates, when appropriate. Proper coding in medical certificates is important for documenting the condition that justifies absence from activities or need for workplace accommodations. However, the description should be sufficiently clear so that non-specialists understand the nature of the condition and its functional implications.

Can degenerative disorders of the ear be reversed?

Unfortunately, true degenerative processes are generally not reversible, as they involve permanent loss or deterioration of cellular and tissue structures. The goal of treatment is typically to slow progression, preserve residual function, and manage symptoms. In some cases of vascular compromise, interventions to improve circulation may stabilize or occasionally improve function, but complete reversal is rare. Rehabilitation and assistive devices become important for maximizing function despite degeneration.

What risk factors increase the probability of these disorders?

Various factors can increase the risk of degenerative or vascular disorders of the ear. Vascular factors include hypertension, diabetes, dyslipidemia, smoking, and cardiovascular diseases. Aging is a risk factor, although the pathological processes of AB71 should be distinguished from normal physiological aging. History of noise exposure, use of ototoxic medications, and certain autoimmune conditions can also predispose to degenerative processes. Identification and control of these risk factors is important in prevention and management.

Is there a difference between degenerative and vascular disorders of the ear?

Although grouped under the same code, there are conceptual differences. Degenerative disorders refer to progressive deterioration of auricular structures due to intrinsic processes of pathological aging or cellular wear. Vascular disorders involve compromise of blood circulation to ear structures, resulting in ischemia and dysfunction. In clinical practice, these processes frequently coexist, as vascular insufficiency can accelerate degeneration, and degenerative structures may have greater vulnerability to circulatory compromise.

How to differentiate this disorder from normal age-related hearing loss?

Differentiation is based on multiple factors. Presbycusis (age-related hearing loss) typically occurs after 60-65 years of age, presents a characteristic audiometric pattern with predominant loss at high frequencies and slow and symmetric progression. Pathological degenerative disorders (AB71) can occur at younger ages, present faster progression, significant asymmetry, or atypical audiometric patterns. Imaging findings demonstrating specific structural changes also support the diagnosis of pathological process beyond normal aging. The distinction is clinically important because it influences management and prognosis.

Conclusion

The ICD-11 code AB71 for degenerative or vascular disorders of the ear represents an important tool for the precise classification of conditions that progressively affect auditory and vestibular function. Proper coding requires clear understanding of diagnostic criteria, differentiation of related conditions, and detailed documentation of clinical and complementary findings. Early recognition and appropriate management of these conditions are fundamental to preserving patients' quality of life and optimizing long-term functional outcomes.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Degenerative or vascular disorders of the ear

Compartilhar